Celanese Corp
NYSE:CE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Celanese Corp
NYSE:CE
|
US |
|
I
|
Impala Platinum Holdings Ltd
JSE:IMP
|
ZA |
|
Berlina Tbk PT
IDX:BRNA
|
ID |
|
C4 Therapeutics Inc
NASDAQ:CCCC
|
US |
|
P
|
Pinnacle West Capital Corp
DUS:PWC
|
US |
|
N
|
Nov Inc
XMUN:NO8
|
US |
|
Five Below Inc
NASDAQ:FIVE
|
US |
|
Innate Pharma SA
F:IDD
|
FR |
|
E
|
Enterprise Products Partners LP
LSE:0S23
|
US |
|
U
|
Unity Software Inc
F:US3
|
US |
Wall St Price Targets
CE Price Targets Summary
Celanese Corp
According to Wall Street analysts, the average 1-year price target for CE is 75.379 USD with a low forecast of 64.64 USD and a high forecast of 99.141 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CE's stock price target?
Price Target
75.379
USD
According to Wall Street analysts, the average 1-year price target for CE is 75.379 USD with a low forecast of 64.64 USD and a high forecast of 99.141 USD.
What is the Revenue forecast for Celanese Corp?
Projected CAGR
3%
Over the last 13 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 5 years is 3%.
What is the Gross Profit forecast for Celanese Corp?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 4%. The projected CAGR for the next 5 years is 7%.
What is the Operating Income forecast for Celanese Corp?
Projected CAGR
13%
Over the last 13 years, the compound annual growth rate for Operating Income has been 11%. The projected CAGR for the next 5 years is 13%.
